270 related articles for article (PubMed ID: 11175327)
21. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
Primo J; Siqueira I; Nascimento MC; Oliveira MF; Farre L; Carvalho EM; Bittencourt AL
Braz J Med Biol Res; 2009 Aug; 42(8):761-4. PubMed ID: 19578703
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
23. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
24. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
[TBL] [Abstract][Full Text] [Related]
25. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.
Hayashi D; Kubota R; Takenouchi N; Nakamura T; Umehara F; Arimura K; Izumo S; Osame M
J Neurovirol; 2008 Oct; 14(5):459-63. PubMed ID: 18989817
[TBL] [Abstract][Full Text] [Related]
27. Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.
Lins L; de Carvalho VJ; de Almeida Rego FF; Azevedo R; Kashima S; Gallazi VN; Xavier MT; Galvão-Castro B; Alcantara LC
J Med Virol; 2012 Sep; 84(9):1428-36. PubMed ID: 22825822
[TBL] [Abstract][Full Text] [Related]
28. Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Yamano Y; Jacobson S; Taylor GP; Martin F; Galvão-Castro B
J Clin Virol; 2013 Nov; 58(3):584-6. PubMed ID: 24095029
[No Abstract] [Full Text] [Related]
29. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
30. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
[TBL] [Abstract][Full Text] [Related]
31. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
Nascimento MC; Primo J; Bittencourt A; Siqueira I; de Fátima Oliveira M; Meyer R; Schriefer A; Santos SB; Carvalho EM
Clin Exp Immunol; 2009 Jun; 156(3):455-62. PubMed ID: 19438598
[TBL] [Abstract][Full Text] [Related]
32. Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.
Domingos JA; Soares LS; Bandeira LM; Bonin CM; Vicente AC; Zanella L; Puga MA; Tozetti IA; Motta-Castro AR; da Cunha RV
PLoS One; 2017; 12(4):e0174869. PubMed ID: 28376092
[TBL] [Abstract][Full Text] [Related]
33. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
34. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.
Yakova M; Lézin A; Dantin F; Lagathu G; Olindo S; Jean-Baptiste G; Arfi S; Césaire R
Retrovirology; 2005 Feb; 2():4. PubMed ID: 15686595
[TBL] [Abstract][Full Text] [Related]
35. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
Martins ML; Guimarães JC; Ribas JG; Romanelli LC; de Freitas Carneiro-Proietti AB
J Neurovirol; 2017 Feb; 23(1):125-133. PubMed ID: 27678093
[TBL] [Abstract][Full Text] [Related]
37. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
Ramirez E; Cartier L; Torres M; Barria M
J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
[TBL] [Abstract][Full Text] [Related]
38. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
39. Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis.
Gois LL; Ribeiro-Soares B; Regis-Silva CG; Zanette DL; Lisboa R; Nascimento RS; Coutinho Junior R; Galvão-Castro B; Grassi MFR
BMC Infect Dis; 2024 Jun; 24(1):652. PubMed ID: 38943078
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Nakamura T; Nishiura Y; Eguchi K
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
